Skip to main content
. 2022 Mar 29;12(11):4235–4248. doi: 10.1016/j.apsb.2022.03.015

Figure 6.

Figure 6

In vivo fate of RM-PL+Hlα after intravenous injection. (A) Circulation profiles of RM-PL+Hlα after intravenous injection (n = 4). (B) Biodistribution of RM-PL+Hlα at 24 h after intravenous injection (mean ± SD, n = 4). ∗P < 0.05, compared with RM-PL. (C) Flow histograms of different types of splenic cells internalized DiD-labeled RM-PL+Hlα. (D) Flow histograms of different types of liver cells internalizing DiD-labeled RM-PL+Hlα. (E, F) The corresponding mean fluorescence intensity (MFI) of different cells (E) in the spleen and (F) in the liver internalizing DiD-labeled RM-PL+Hlα (mean ± SD, n = 4).